Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  2007-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-4095PMID 17545622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasmalemmal vacuolar-type H+-ATPase in cancer biology

  2007cited by this paper
• The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.

  2006cited by this paper
• Cytosolic acidification and lysosomal alkalinization during TNF-α induced apoptosis in U937 cells

  2006cited by this paper
• Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.

  2006cited by this paper
• Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.

  2005cited by this paper
• Safety of potent gastric acid inhibition.

  2005cited by this paper
• Lysosomes and autophagy in cell death control

  2005influential reference
• The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.

  2005cited by this paper
• Tumor acidity, chemoresistance and proton pump inhibitors.

  2005cited by this paper
• Characterization of cells with different mitochondrial membrane potential during apoptosis

  2005cited by this paper
• Proton pump inhibitors may reduce tumour resistance

  2005cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.

  2004cited by this paper
• Role of AIF in caspase-dependent and caspase-independent cell death

  2004cited by this paper
• Treatment advances in adult Burkitt lymphoma and leukemia

  2004cited by this paper
• Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity.

  2004cited by this paper
• Omeprazole Induces Apoptosis in Jurkat Cells

  2004cited by this paper
• Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry.

  2003cited by this paper
• An overview of proton pump inhibitors.

  2003cited by this paper
• Extracellular acidification alters lysosomal trafficking in human breast cancer cells.

  2003cited by this paper
• Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1.

  2003cited by this paper
• Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy.

  2003influential reference
• Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion

  2003influential reference
• The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.

  2003cited by this paper
• Antileishmanial Activity of the Antiulcer Agent Omeprazole

  2002cited by this paper
• Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.

  2002cited by this paper
• The vacuolar (H+)-ATPases — nature's most versatile proton pumps

  2002cited by this paper
• Elevated expression of vacuolar proton pump genes and cellular ph in cisplatin resistance

  2001cited by this paper
• Fluorescence lifetime characterization of novel low-pH probes.

  2001cited by this paper
• Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species.

  2001cited by this paper
• A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas

  2001cited by this paper
• Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells

  2001cited by this paper
• Recent advances in management of acute leukaemia

  2000cited by this paper
• The proton-pump inhibitors: similarities and differences.

  2000cited by this paper
• Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger.

  2000cited by this paper
• The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects.

  1999cited by this paper
• pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines.

  1999cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp

  1997cited by this paper
• Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.

  1995cited by this paper
• Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.

  1995cited by this paper
• In vivo effect of omeprazole on HLA-DR expression and the monocyte-macrophage function in patients with duodenal ulcer disease.

  1994cited by this paper
• H(+)-ATPases of renal cortical and medullary endosomes are differentially sensitive to Sch-28080 and omeprazole.

  1994cited by this paper
• Evidence for a common binding site for omeprazole and N-ethylmaleimide in subunit A of chromaffin granule vacuolar-type H(+)-ATPase.

  1993cited by this paper
• Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells.

  1993cited by this paper
• Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials.

  1992cited by this paper
• Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells.

  1991cited by this paper
• Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.

  1991cited by this paper
• Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts

  1990cited by this paper
• ©1999 Cancer Research Campaign Article no. bjoc.1998.0455 Enhancement of chemotherapy by manipulation of tumour pH

  year unknowncited by this paper

• Multiscale imaging on proton pump-driven acidity for assessing tumor progression and metastasis

  2026cites this paper
• Proton pump inhibitors accelerate vascular calcification via COX-2-mediated mitophagy inhibition in chronic kidney disease.

  2026cites this paper
• Single-Cell Analysis with Spatiotemporal Control of Local pH

  2025cites this paper
• In vitro combination effects and mechanisms of Revaprazan with Triazole antifungal drugs on Aspergillus

  2025cites this paper
• Modulating Tumor Cell Extracellular Vesicle Signaling for Therapeutic Intervention and Monitoring

  2025cites this paper
• Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines.

  2025cites this paper
• In situ cryo-ET redefines HPV disassembly and transport paradigms

  2025cites this paper
• Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database

  2024cites this paper
• Protocol for detecting lysosome quantity and membrane permeability in acute myeloid leukemia cell lines

  2024cites this paper
• Acid affairs in anti-tumour immunity

  2024cites this paper
• Omeprazole-Loaded Copper Nanoparticles for Mitochondrial Damage Mediated Synergistic Anticancer Activity against Melanoma Cells.

  2024cites this paper
• Proton pump inhibitor attenutes acidic microenvironment to improve the therapeutic effects of MSLN-CAR-T cells on the brain metastasis of solid tumors.

  2024cites this paper
• pH-independent effects of acid suppressants in dogs and cats: a One Health perspective and case for further investigation.

  2024cites this paper
• How Does Cancer Occur? How Should It Be Treated? Treatment from the Perspective of Alkalization Therapy Based on Science-Based Medicine

  2024cites this paper
• The acidic microenvironment in the perisinusoidal space critically determines bile salt-induced activation of hepatic stellate cells

  2024cites this paper
• Underlying Mechanism of Lysosomal Membrane Permeabilization in CNS Injury: A Literature Review

  2024cites this paper
• Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration.

  2024cites this paper
• Integrin-Specific Stimuli-Responsive Nanomaterials for Cancer Theranostics

  2024cites this paper
• Intra-Lysosomal Peptide Assembly for the High Selectivity Index against Cancer.

  2023cites this paper
• Synergistic Effect of Metformin and Lansoprazole Against Gastric Cancer through Growth Inhibition

  2023cites this paper
• IDH1 K224 acetylation promotes colorectal cancer via miR-9-5p/NHE1 axis-mediated regulation of acidic microenvironment

  2023cites this paper
• New approaches to radio- and chemosensitization using proton pump inhibitors through the lens of tumor cell microenvironment patterns

  2023cites this paper
• Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study

  2023cites this paper
• Omeprazole induces profibrotic gene expression in rat kidney: implication of TGF-β/Smad signaling pathway

  2023cites this paper
• Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study

  2023cites this paper
• Potential of Alkalization Therapy for the Management of Metastatic Pancreatic Cancer: A Retrospective Study

  2023cites this paper
• The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A Review

  2022cites this paper
• The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis

  2022cites this paper
• Meaning and Significance of “Alkalization Therapy for Cancer”

  2022cites this paper
• Proton pump inhibitors and sensitization of cancer cells to radiation therapy

  2022cites this paper
• Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

  2022cites this paper
• Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals

  2022cites this paper
• Back to basic: Trials and tribulations of alkalizing agents in cancer

  2022cites this paper
• Experiment versus theory of copper (II) complexes based imidazole derivatives as anti-cancer agents

  2022cites this paper
• A review on lactoferrin as a proton pump inhibitor.

  2022cites this paper
• In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models

  2022cites this paper
• Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach

  2022cites this paper
• Long term use of Proton Pump Inhibitor disrupts intestinal tight junction barrier and exaggerates experimental colitis.

  2022cites this paper
• Synergistic Anti-tumor Effect of Dichloroacetate and Ivermectin

  2022cites this paper
• Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification

  2022cites this paper
• Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases

  2022cites this paper
• Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy

  2022cites this paper
• Mitochondrion-Mediated Cell Death through Erk1-Alox5 Independent of Caspase-9 Signaling

  2022cites this paper
• Cognition, oxidative stress and vitamin B12 levels evaluation on patients under long-term omeprazole use.

  2021cites this paper
• Overcoming Chemoresistance: Altering pH of Cellular Compartments by Chloroquine and Hydroxychloroquine

  2021cites this paper
• Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo

  2021cites this paper
• Lysosomes and Cancer Progression: A Malignant Liaison

  2021cites this paper
• Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis

  2021cites this paper
• Omeprazole suppresses aggressive cancer growth and metastasis in mice through promoting Snail degradation

  2021cites this paper
• Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path

  2021cites this paper
• Omeprazole activates the mitogenic cell response in rat kidney: Implication of ERK1/2 signaling cascade

  2021cites this paper
• Loss of vacuolar-type H+-ATPase induces caspase-independent necrosis-like death of hair cells in zebrafish neuromasts

  2021cites this paper
• pH and electrolytes metabolism in prostate cancer

  2021cites this paper
• New hypotheses for cancer generation and progression.

  2021cites this paper
• Loss of vacuolar type H+-ATPase induces caspase-independent necrosis-like death of hair cells in zebrafish neuromast.

  2021cites this paper
• Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole

  2021cites this paper
• Metabolic hallmarks of cancer cells as targets for integrative therapies

  2021cites this paper
• Proton pump inhibitors and other pH-buffering agents

  2021cites this paper
• Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation

  2021cites this paper
• Extracellular vesicles (EVs): What we know of the mesmerizing roles of these tiny vesicles in hematological malignancies?

  2021cites this paper
• Esomeprazole enhances the effect of ionizing radiation to improve tumor control

  2021cites this paper
• Dendronized‐Polymer Disturbing Cells' Stress Protection by Targeting Metabolism Leads to Tumor Vulnerability

  2020cites this paper
• Molecular pathways driving omeprazole nephrotoxicity

  2020cites this paper
• Lactate in Sarcoma Microenvironment: Much More than just a Waste Product

  2020cites this paper
• Pantoprazole abrogated cisplatin-induced nephrotoxicity in mice via suppression of inflammation, apoptosis, and oxidative stress

  2020cites this paper
• Dual targeting of tumor cell energy metabolism and lysosomes as an anticancer strategy.

  2020cites this paper
• The Acidic Microenvironment: Is It a Phenotype of All Cancers? A Focus on Multiple Myeloma and Some Analogies with Diabetes Mellitus

  2020cites this paper
• The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences

  2020cites this paper
• N-Acetylcysteine Reverses Antiretroviral-Mediated Microglial Activation by Attenuating Autophagy-Lysosomal Dysfunction

  2020cites this paper
• Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells

  2020cites this paper
• In vivo anti‐V‐ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses

  2020cites this paper
• Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer

  2020cites this paper
• The impact of tumour pH on cancer progression: strategies for clinical intervention

  2020cites this paper
• Iron Promotes Dihydroartemisinin Cytotoxicity via ROS Production and Blockade of Autophagic Flux via Lysosomal Damage in Osteosarcoma

  2020cites this paper
• New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention

  2020cites this paper
• The vacuolar H+ ATPase proton pump

  2020cites this paper
• Vacuolar-ATPase proton pump inhibition in cancer therapy: Veterinary and human experience

  2020cites this paper
• Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells

  2020cites this paper
• Pharmacological interventions part II

  2020cites this paper
• Induction of Erythrocyte Shrinkage by Omeprazole

  2020cites this paper
• Pantoprazole attenuates tumorigenesis via inhibition of exosomal secretion in a rat model of hepatic precancerous lesion induced by diethylnitrosamine and 2‐acetamidofluorene

  2019cites this paper
• The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders

  2019cites this paper
• Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.

  2019cites this paper
• Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms

  2019cites this paper
• Magnetic and pH-responsive magnetic nanocarriers

  2019cites this paper
• Stimuli-responsive polymeric micelles for extracellular and intracellular drug delivery

  2019cites this paper
• A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics

  2019cites this paper
• Unexpected Discoveries Should Be Reconsidered in Science—A Look to the Past?

  2019cites this paper
• Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo.

  2019cites this paper
• Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.

  2019cites this paper
• Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells

  2019cites this paper
• Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors

  2019cites this paper
• Oral Administration of Fermented Papaya (FPP®) Controls the Growth of a Murine Melanoma through the In Vivo Induction of a Natural Antioxidant Response

  2019cites this paper
• Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells

  2019cites this paper
• Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity

  2019cites this paper
• Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns

  2018cites this paper
• Hepatocyte‐specific deletion of LASS2 protects against diet‐induced hepatic steatosis and insulin resistance

  2018cites this paper
• Stoffwechselmerkmale der Tumorzellen als Ziel komplementärer Therapien

  2018cites this paper
• Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population‐Based Study

  2018cites this paper
• Pantoprazole Induces Mitochondrial Apoptosis and Attenuates NF-κB Signaling in Glioma Cells

  2018cites this paper